2 studies on Acth stimulation mechanism curated from PubMed, ClinicalTrials.gov, and EuropePMC. Updated daily.
**GHRP-2 may offer a clinically viable, lower-risk alternative to ITT** for diagnosing secondary adrenal insufficiency in patients with hypopituitarism — a group in whom insulin-induced hypoglycemia carries elevated d…
**GHRP-2 testing may offer a safer, equally informative alternative to ITT** for evaluating adrenal reserve in patients with hypothalamic or pituitary disease, particularly those for whom insulin-induced hypoglycemia …